CMS is adding value-based care (VBC) risk faster than many providers can build the data and tech capacity they need to succeed.
News|Articles|February 4, 2025
Braidwood Case Headed to Supreme Court, Coverage for Preventive Care in Jeopardy
Author(s)Julia Bonavitacola
Insurance coverage of preventive care is on the line as Braidwood Management v Becerra moves to the Supreme Court this year.
Advertisement
Advertisement
Changes to the ways that preventive care is covered by insurance may be in the cards as the Braidwood Management v Becerra case makes it way to the Supreme Court this year. The decision could erode mandates that guarantee coverage of both HIV and oncology preventive treatments, leaving many to reevaluate how they get their medication and their screening services.
Related to this article
Phase 3 wins for ianalumab and dazodalibep bring targeted therapies closer for Sjögren disease as patients face diagnostic delays and high costs.
FDA accepted United Therapeutics' sNDA for inhaled treprostinil in IPF. Here's what it could mean for patient access, coverage, and costs
CAR T-cell therapy must be treated as a complete "vein-to-vein" episode, with community practices needing to take control of cases for a period of time.
Payers cover novel cancer drugs but not the staffing, training, and monitoring to deliver them, leaving practices to absorb costs.
This moves the noncovalent BTK inhibitor into the first-line setting for certain adults with chronic lymphocytic leukemia or small lymphocytic lymphoma.
Patch testing in Malaysia finds contact dermatitis drivers in chronic hand eczema—nickel and fragrance allergy lead, while cosmetics raise polysensitization risk.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Advertisement
Advertisement